Quitting Caffeine for Better Glucose Metabolism

Completed · Phase 1

Conditions studied: Diabetes Mellitus, Type 2

In brief

This project is a pilot study of caffeine abstinence in coffee-drinkers who have type 2 diabetes. Evidence suggests that caffeine may impair the control of glucose levels, especially in those people who have type 2 diabetes. Eliminating caffeinated beverages from the diet might improve glucose control, but the difficulty of quitting is unknown. This pilot study will follow a small number of type 2 diabetic patients for three months after a brief intervention designed to help people quit caffeine. Data on success with maintaining abstinence and on changes in glucose control will be collected.

Key facts

Study ID

NCT01030796

Run by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

People needed

25

Starts

2009-12-01

Expected to finish

2010-04-01

Last updated by the study team

2011-02-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 6-month history of type 2 diabetes
• impaired chronic glucose control (HbA1c >= 7%)
• daily consumption of 250 mg caffeine or more in coffee, tea, and other caffeinated beverages

You may not qualify if…

• use of exogenous insulin
• use of non-diabetes medications that impact glucose metabolism
• medical of psychiatric history that prevents participation or increases risk
• current pregnancy
• current participation in other clinical trials
• deemed unable to comply with the study protocol for other reasons

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.